Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery - podcast episode cover

Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery

Jun 13, 202349 minEp. 24
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.

 

00:00 intro

00:59 Daphne’s journey

09:02 AI and biology discovery

10:42 insitro vs. traditional pharma

19:47 phenotyping patients

25:44 early mistakes

29:34 the future of data

35:16 partnering with larger pharma companies

38:00 impact of LLMs on biopharma

43:47 over-hyped/under-hyped

For the best experience, listen in Metacast app for iOS or Android